If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
273.00    3.00 (1.11%)
Bid:
273.00
Ask:
277.00
Spread: 4.00 (1.465%)
Market Cap: £244.49m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Director/PDMR Shareholding

Today 11:20

RNS Number : 3422L
Wilmington PLC
07 July 2026
 

7 July 2026

 

Wilmington plc

Director/PDMR Shareholding

 

 

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, on 7 July 2026 Ruth Abdey's (PDMR) options under the Wilmington SAYE Plan 2018 (the 'SAYE Scheme') were exercised, at an exercise price of £2.45 per share. The movement is set out below:

Individual

Position

Number of Vested Shares

Resultant share holding (Number)

Resultant share holding as a % of the issued share capital with voting rights

Ruth Abdey

PDMR

7,346

35,938

0.04%

 

 

 

 

For further information, please contact:

Wilmington plc 

Guy Millward, CFO and Company Secretary 020 7490 0049

Meare Consulting

Adrian Duffield 07990 858548

The information contained within this announcement is deemed to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this inside information is now considered to be in the public domain.

Notes to Editors

Wilmington plc is an international Governance, Risk and Compliance (GRC) RegTech services group providing a range of regulatory learning & training, regulation intelligence & data capabilities across the HSE (Health, Safety and ESG), legal, data privacy and financial services sectors.

The Group has a proprietary RegTech platform with embedded AI, employing the Model Context Protocol (MCP) to interface through an orchestration layer with its many enterprise systems. It has developed its own Autonomous Responsive Intelligence Assistant (ARIA) which enables it to connect or link, manage or automate activities across multiple data repositories, software and different AI models.

Wilmington employs over 1,100 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

 

a)

Name

RUTH ABDEY

 

2.

Reason for the notification

 

a)

Position /status

PDMR

 

b)

Initial notification / amendment

 

INITIAL NOTIFICATION

3.

Details of the Issuer

 

a)

Name

WILMINGTON PLC

 

b)

LEI code

 

213800PFUQT4HHFYZJ63

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

ORDINARY SHARES IN WILMINGTON PLC

 

ISIN: GB0009692319

 

b)

Nature of the transaction

VESTING OF OPTIONS OF ORDINARY SHARES UNDER THE WILMINGTON SAYE PLAN 2018

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

2.45

7,346

 

 

d)

Aggregated information

Aggregated volume

Price

 

 

 

N/A

 

 

e)

Date of the transaction

7 JULY 2026

 

 

f)

Place of the transaction

LONDON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHRRMMTMTBMBLF
Date   Source Headline
7th Jul 202611:20 amRNSDirector/PDMR Shareholding
17th Apr 202611:20 amRNSHolding(s) in Company
15th Apr 20263:56 pmRNSBoard changes
15th Apr 202611:21 amRNSSave As You Earn Options
11th Mar 202611:00 amRNSDirector Declaration
11th Mar 202611:00 amRNSDirector Declaration
26th Feb 20267:00 amRNSHalf-year Financial Report
11th Feb 20262:44 pmRNSNotice of half year-end results
21st Jan 202611:19 amRNSNotice of Half Year Results
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Dec 20257:00 amRNSAppointment of Joint Corporate Broker
5th Dec 20259:56 amRNSAcquisition of Conversia completed
28th Nov 20254:23 pmRNSDirector/PDMR Shareholding
28th Nov 202511:22 amRNSAcquisition of Conversia cleared to complete
25th Nov 20259:19 amRNSResult of AGM
10th Nov 20255:54 pmRNSDirectorate change
1st Oct 20252:51 pmRNSDirector/PDMR Shareholding
1st Oct 20252:49 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
22nd Sep 202512:48 pmRNSDirector/PDMR Shareholding- Replacement
22nd Sep 202511:52 amRNSDirector/PDMR Shareholding
22nd Sep 20257:00 amRNSFinancial results for the year ended 30 June 2025
5th Sep 202510:58 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSNotice of year-end results
29th Aug 202511:07 amRNSHolding(s) in Company
12th Aug 20257:03 amRNSProposed acquisition of Conversia
12th Aug 20257:00 amRNSDirector Declaration
1st Aug 20257:00 amRNSAppointment of Joint Corporate Broker
30th Jul 20257:00 amRNSStatement in relation to a potential acquisition
23rd Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20259:00 amRNSDirector/PDMR Shareholding
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20259:30 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.